All Stories

  1. Aberrant overexpression of FOXM1 transcription factor plays a critical role in lung carcinogenesis induced by low doses of arsenic

    Article • Molecular Carcinogenesis, December 2012, Wiley

    Dr Janet M Hock

  2. Novel Interactions between FOXM1 and CDC25A Regulate the Cell Cycle

    Article • PLoS ONE, December 2012, PLOS

    Dr Janet M Hock

  3. MicroRNA-204 critically regulates carcinogenesis in malignant peripheral nerve sheath tumors

    Article • Neuro-Oncology, June 2012, Oxford University Press (OUP)

    Dr Janet M Hock

  4. Analyzing Spatial and Temporal 222Rn Trends in Maine

    Article • Health Physics, February 2012, Wolters Kluwer Health

    Dr Janet M Hock

  5. A novel animal model for bone metastasis in human lung cancer

    Article • Oncology Letters, February 2012, Spandidos Publications

    Dr Janet M Hock

  6. Unmet Challenges in Cancer Disparities--Letter

    Article • Cancer Epidemiology Biomarkers & Prevention, December 2011, American Association for Cancer Research (AACR)

    Dr Janet M Hock

  7. Hyperactivation of mTOR critically regulates abnormal osteoclastogenesis in neurofibromatosis type 1

    Article • Journal of Orthopaedic Research®, July 2011, Wiley

    Dr Janet M Hock

  8. Lawrence G. Raisz November 13, 1925-August 25, 2010

    Article • Journal of Bone and Mineral Research, May 2011, Wiley

    Dr Janet M Hock

  9. Activation of the p38 MAPK/Akt/ERK1/2 signal pathways is required for the protein stabilization of CDC6 and cyclin D1 in low-dose arsenite-induced cell proliferation

    Article • Journal of Cellular Biochemistry, November 2010, Wiley

    Dr Janet M Hock

  10. Hyperactivation of mTOR critically regulates abnormal osteoclastogenesis in neurofibromatosis Type 1

    Article • Bone, October 2010, Elsevier

    Dr Janet M Hock

  11. Abnormal osteoblast development from Nf1 null embryonic stem cells

    Article • Bone, October 2010, Elsevier

    Dr Janet M Hock

  12. MicroRNA-10b regulates tumorigenesis in neurofibromatosis type 1

    Article • Cancer Science, August 2010, Wiley

    Dr Janet M Hock

  13. Psychosocial adjustment of siblings of children with cancer: a systematic review

    Article • Psycho-Oncology, October 2009, Wiley

    Dr Janet M Hock

  14. Skeletal abnormalities in neurofibromatosis type 1: Approaches to therapeutic options

    Article • American Journal of Medical Genetics Part A, October 2009, Wiley

    Dr Janet M Hock

  15. Determination of the Fate and Contribution of Ex Vivo Expanded Human Bone Marrow Stem and Progenitor Cells for Bone Formation by 2.3ColGFP

    Article • Molecular Therapy, July 2009, Nature

    Dr Janet M Hock

  16. Proteomic Characteristics of ex vivo -Enriched Adult Human Bone Marrow Mononuclear Cells in Continuous Perfusion Cultures

    Article • Journal of Proteome Research, April 2009, American Chemical Society (ACS)

    Dr Janet M Hock

  17. IGF-I improved bone mineral density and body composition of weaver mutant mice

    Article • Growth Hormone & IGF Research, December 2008, Elsevier

    Dr Janet M Hock

  18. Hyperactivation of p21ras and PI3K cooperate to alter murine and human neurofibromatosis type 1–haploinsufficient osteoclast functions

    Article • Journal of Clinical Investigation, November 2006, American Society for Clinical Investigation

    Dr Janet M Hock

  19. Serum proteome profiles identifies parathyroid hormone physiologic response

    Article • PROTEOMICS, June 2006, Wiley

    Dr Janet M Hock

  20. RECQL4-deficient cells are hypersensitive to oxidative stress/damage: Insights for osteosarcoma prevalence and heterogeneity in Rothmund-Thomson syndrome

    Article • Biochemical and Biophysical Research Communications, June 2006, Elsevier

    Dr Janet M Hock

  21. Recql4 haploinsufficiency in mice leads to defects in osteoblast progenitors: Implications for low bone mass phenotype

    Article • Biochemical and Biophysical Research Communications, May 2006, Elsevier

    Dr Janet M Hock

  22. Neurofibromatosis Type 1 Gene Haploinsufficiency Reduces AP-1 Gene Expression without Abrogating the Anabolic Effect of Parathyroid Hormone

    Article • Calcified Tissue International, March 2006, Springer Science + Business Media

    Dr Janet M Hock

  23. Neurofibromin and its inactivation of Ras are prerequisites for osteoblast functioning

    Article • Bone, May 2005, Elsevier

    Dr Janet M Hock

  24. IGF-I and Postnatal Growth of Weaver Mutant Mice

    Article • Endocrine, January 2005, Springer Science + Business Media

    Dr Janet M Hock

  25. Periosteum: biology, regulation, and response to osteoporosis therapies

    Article • Bone, November 2004, Elsevier

    Dr Janet M Hock, Dr Matthew R Allen

  26. Anabolic and catabolic bone effects of human parathyroid hormone (1-34) are predicted by duration of hormone exposure

    Article • Bone, September 2003, Elsevier

    Dr Janet M Hock

  27. Skeletal Efficacy with Parathyroid Hormone in Rats Was Not Entirely Beneficial with Long-Term Treatment

    Article • Journal of Pharmacology and Experimental Therapeutics, July 2002, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Dr Janet M Hock

  28. Osteoblast intracellular localization of Nmp4 proteins

    Article • Bone, June 2002, Elsevier

    Dr Janet M Hock

  29. Parathyroid hormone (hPTH 1-38) stimulates the expression of UBP41, an ubiquitin-specific protease, in bone

    Article • Journal of Cellular Biochemistry, January 2002, Wiley

    Dr Janet M Hock

  30. Overview

    Article • Endocrine, January 2002, Springer Science + Business Media

    Dr Janet M Hock

  31. Effects of human parathyroid hormone (1-34), LY333334, on bone mass, remodeling, and mechanical properties of cortical bone during the first remodeling cycle in rabbits

    Article • Bone, May 2001, Elsevier

    Dr Janet M Hock

  32. Treatment with human parathyroid hormone (1-34) for 18 months increases cancellous bone volume and improves trabecular architecture in ovariectomized cynomolgus monkeys (Macaca fascicularis)

    Article • Bone, February 2001, Elsevier

    Dr Janet M Hock

  33. In vivo comparison of activated protein-1 gene activation in response to human parathyroid hormone (hPTH)(1–34) and hPTH(1–84) in the distal femur metaphyses of young mice

    Article • Bone, December 2000, Elsevier

    Dr Janet M Hock

  34. ADAMTS-1: A Cellular Disintegrin and Metalloprotease with Thrombospondin Motifs Is a Target for Parathyroid Hormone in Bone

    Article • Endocrinology, December 2000, Endocrine Society

    Dr Janet M Hock

  35. Discrimination among osteoblasts? Parathyroid hormone analog may reveal site-specific differences in mice

    Article • Bone, October 2000, Elsevier

    Dr Janet M Hock

  36. In vivo regulation of apoptosis in metaphyseal trabecular bone of young rats by synthetic human parathyroid hormone (1-34) fragment

    Article • Bone, August 2000, Elsevier

    Dr Janet M Hock

  37. Changes in Geometry and Cortical Porosity in Adult, Ovary-Intact Rabbits after 5 Months Treatment with LY333334 (hPTH 1-34)

    Article • Calcified Tissue International, June 2000, Springer Science + Business Media

    Dr Janet M Hock

  38. The expression of the nuclear matrix proteins NuMA, topoisomerase II-α, and -β in bone and osseous cell culture: regulation by parathyroid hormone

    Article • Bone, March 2000, Elsevier

    Dr Janet M Hock

  39. Dynamic Regulation of RGS2 in Bone: Potential New Insights into Parathyroid Hormone Signaling Mechanisms

    Article • Endocrinology, January 2000, Endocrine Society

    Dr Janet M Hock

  40. Immunohistochemical Localization of Selected Early Response Genes Expressed in Trabecular Bone of Young Rats Given hPTH 1-34

    Article • Calcified Tissue International, November 1999, Springer Science + Business Media

    Dr Janet M Hock

  41. Stemming bone loss by suppressing apoptosis

    Article • Journal of Clinical Investigation, August 1999, American Society for Clinical Investigation

    Dr Janet M Hock

  42. Molecular Characterization of Gene Expression Changes in ROS 17/2.8 Cells Cultured in Diffusion Chambers In Vivo

    Article • Calcified Tissue International, August 1999, Springer Science + Business Media

    Dr Janet M Hock

  43. The Addition of a Raloxifene Analog (LY117018) Allows for Reduced PTH(1-34) Dosing During Reversal of Osteopenia in Ovariectomized Rats

    Article • Journal of Bone and Mineral Research, May 1999, Wiley

    Dr Janet M Hock

  44. Parathyroid Hormone Regulates the Expression of Fibroblast Growth Factor-2 mRNA and Fibroblast Growth Factor Receptor mRNA in Osteoblastic Cells

    Article • Journal of Bone and Mineral Research, May 1999, Wiley

    Dr Janet M Hock

  45. Assessment of maintenance therapy with reduced doses of PTH(1-34) in combination with a raloxifene analogue (LY117018) following anabolic therapy in the ovariectomized rat

    Article • Bone, May 1999, Elsevier

    Dr Janet M Hock

  46. Comparison of Recombinant Human PTH(1-34) (LY333334) with a C-Terminally Substituted Analog of Human PTH-Related Protein(1-34) (RS-66271): In Vitro Activity and In Vivo Pharmacological Effects in Rats

    Article • Journal of Bone and Mineral Research, February 1999, Wiley

    Dr Janet M Hock

  47. Intermittent administration of parathyroid hormone (1-34) stimulates matrix metalloproteinase-9 (MMP-9) expression in rat long bone

    Article • Journal of Cellular Biochemistry, September 1998, Wiley

    Dr Janet M Hock

  48. PTH-responsive osteoblast nuclear matrix architectural transcription factor binds to the rat type I collagen promoter

    Article • Journal of Cellular Biochemistry, June 1998, Wiley

    Dr Janet M Hock

  49. Recruitment and Proliferative Responses of Osteoblasts After Mechanical Loading In Vivo Determined Using Sustained-Release Bromodeoxyuridine

    Article • Bone, May 1998, Elsevier

    Dr Janet M Hock

  50. Parathyroid Hormone Regulates the Expression of the Nuclear Mitotic Apparatus Protein in the Osteoblast-like Cells, ROS 17/2.8

    Article • Bone, April 1998, Elsevier

    Dr Janet M Hock

  51. Analysis of differential gene expression in rat tibia after an osteogenic stimulus in vivo: Mechanical loading regulates osteopontin and myeloperoxidase

    Article • Journal of Cellular Biochemistry, March 1998, Wiley

    Dr Janet M Hock

  52. Nuclear Matrix Proteins and Osteoblast Gene Expression

    Article • Journal of Bone and Mineral Research, February 1998, Wiley

    Dr Janet M Hock

  53. Osteoprogenitor Cells as Targets for Ex Vivo Gene Transfer

    Article • Journal of Bone and Mineral Research, January 1998, Wiley

    Dr Janet M Hock

  54. Topoisomerase II expression in osseous tissue

    Article • Journal of Cellular Biochemistry, December 1997, Wiley

    Dr Janet M Hock

  55. Parathyroid hormone (1-34)–mediated interleukin-6 induction

    Article • Journal of Cellular Biochemistry, November 1997, Wiley

    Dr Janet M Hock

  56. Proliferating cells in the primary spongiosa express osteoblastic phenotype in vitro

    Article • Bone, February 1997, Elsevier

    Dr Janet M Hock

  57. Article • Molecular Biology Reports, January 1997, Springer Science + Business Media

    Dr Janet M Hock

  58. Rat Osteoblast and Osteosarcoma Nuclear Matrix Proteins Bind with Sequence Specificity to the Rat Type I Collagen Promoter

    Article • Endocrinology, January 1997, Endocrine Society

    Dr Janet M Hock

  59. Parathyroid hormone regulates the expression of rat osteoblast and osteosarcoma nuclear matrix proteins

    Article • Journal of Cellular Biochemistry, December 1996, Wiley

    Dr Janet M Hock

  60. A role for CD8+ T lymphocytes in osteoclast differentiation in vitro

    Article • Endocrinology, June 1996, Endocrine Society

    Dr Janet M Hock

  61. In vivo, human parathyroid hormone fragment (hPTH 1–34) transiently stimulates immediate early response gene expression, but not proliferation, in trabecular bone cells of young rats

    Article • Bone, November 1995, Elsevier

    Dr Janet M Hock

  62. Growth hormone does not enhance the anabolic effect of human parathyroid hormone (1–34) on bone in aging multiparous and virgin rats

    Article • Mechanisms of Ageing and Development, November 1995, Elsevier

    Dr Janet M Hock

  63. Anabolic effect of parathyroid hormone is not modified by supplementation with insulinlike growth factor I (IGF-I) or growth hormone in aged female rats fed an energy-restricted or ad libitum diet

    Article • Bone, February 1995, Elsevier

    Dr Janet M Hock

  64. Growth hormone and parathyroid hormone stimulate intestinal calcium absorption in aged female rats

    Article • Endocrinology, April 1994, Endocrine Society

    Dr Janet M Hock

  65. Platelet-derived growth factor enhances bone cell replication, but not differentiated function of osteoblasts

    Article • Endocrinology, March 1994, Endocrine Society

    Dr Janet M Hock

  66. Anabolic effect of parathyroid hormone on cancellous and cortical bone histology

    Article • Bone, May 1993, Elsevier

    Dr Janet M Hock

  67. Loss of the anabolic effect of parathyroid hormone on bone after discontinuation of hormone in rats

    Article • Bone, January 1989, Elsevier

    Dr Janet M Hock

  68. 1,25 dihydroxyvitamin D3 alone or in combination with parathyroid hormone does not increase bone mass in young rats

    Article • Calcified Tissue International, November 1988, Springer Science + Business Media

    Dr Janet M Hock

  69. Human parathyroid hormone (1–34) and salmon calcitonin do not reverse impaired mineralization produced by high doses of 1,25 dihydroxyvitamin D3

    Article • Calcified Tissue International, July 1986, Springer Science + Business Media

    Dr Janet M Hock

  70. Stimulation of undermineralized matrix formation by 1,25 dihydroxyvitamin D3 in long bones of rats

    Article • Calcified Tissue International, March 1986, Springer Science + Business Media

    Dr Janet M Hock

  71. Autoradiographic study of the effect of 1,25-dihydroxyvitamin D3 on bone matrix synthesis in vitamin D replete rats

    Article • Calcified Tissue International, December 1982, Springer Science + Business Media

    Dr Janet M Hock

  72. Clinical study to compare the effect of stannous fluoride and chlorhexidine mouthrinses on plaque formation

    Article • Journal Of Clinical Periodontology, February 1981, Wiley

    Dr Janet M Hock

  73. A clinical study of gingivitis of deciduous and succadaneous permanent teeth in dogs.

    Article • Journal of Periodontal Research, February 1978, Wiley

    Dr Janet M Hock

  74. Gingival vasculature around erupting deciduous teeth of dogs and cats

    Article • Journal Of Clinical Periodontology, March 1975, Wiley

    Dr Janet M Hock

  75. The organisation of the gingival vasculature

    Article • Journal of Periodontal Research, October 1974, Wiley

    Dr Janet M Hock

  76. Application of fluorescence vital microscopy to the vasculature around erupting teeth

    Article • Microvascular Research, March 1974, Elsevier

    Dr Janet M Hock

  77. A vital microscopy morphology of study of normal the and inflamed gingiva

    Article • Journal of Periodontal Research, April 1971, Wiley

    Dr Janet M Hock